0000950170-24-034247.txt : 20240320 0000950170-24-034247.hdr.sgml : 20240320 20240320165530 ACCESSION NUMBER: 0000950170-24-034247 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240320 ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240320 DATE AS OF CHANGE: 20240320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40499 FILM NUMBER: 24768417 BUSINESS ADDRESS: STREET 1: P.O. BOX 80084 CITY: STONEHAM STATE: MA ZIP: 02180 BUSINESS PHONE: 857-285-4140 MAIL ADDRESS: STREET 1: P.O. BOX 80084 CITY: STONEHAM STATE: MA ZIP: 02180 8-K 1 cyt-20240320.htm 8-K 8-K
0001662244false00016622442024-03-202024-03-20

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 20, 2024

 

 

Cyteir Therapeutics, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40499

45-5429901

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

P.O. Box 80084

 

Stoneham, Massachusetts

 

02180

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 857 285-4140

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

CYT

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 


 

 

 

 

Item 1.02 Termination of Material Definitive Agreement

 

Immediately following the filing of the Certificate of Dissolution (as defined below) with the Secretary of State of the State of Delaware, Cyteir Therapeutics, Inc. (the “Company”) terminated the Company’s Amended and Restated 2012 Stock Incentive Plan, the Company’s 2021 Equity Incentive Plan and the Company’s 2021 Employee Stock Purchase Plan.

 

Item 3.03 Material Modification to Rights of Security Holders.

 

As contemplated by the Plan of Complete Liquidation and Dissolution (the “Plan of Dissolution”) previously approved by the Company’s board of directors (the “Board”) on September 7, 2023 and the Company’s stockholders on November 16, 2023, the Company filed a certificate of dissolution (the “Certificate of Dissolution”) with the Secretary of State of the State of Delaware on March 20, 2024. The Certificate of Dissolution, which became effective upon filing, provides for the dissolution of the Company under the General Corporation Law of the State of Delaware (the “Dissolution”). For additional information regarding the Plan of Dissolution and the Dissolution, please see the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 12, 2023.

 

In connection with the effectiveness of the Certificate of Dissolution, the Board fixed March 20, 2024 as the record date for determining stockholders entitled to receive any future distributions of available assets (the “Common Stock Liquidation Distributions”). Accordingly, the Company instructed its transfer agent to close its stock transfer books and discontinue recording transfers of the Company’s common stock, $0.001 par value per share (the “Common Stock”), effective as of the close of business on March 20, 2024 and to notify DTC of the same. As a result, the Common Stock will no longer be assignable or transferable on the Company’s books, other than transfers by will, intestate succession or operation of law.

 

The Company currently estimates that the aggregate amount of cash that will be available for the Common Stock Liquidation Distributions will be in the range of between $3.10 and $3.16 per share of Common Stock. These amounts may be paid in one or more distributions. The Company currently estimates that it will make its first distribution during the second quarter of 2024.

 

A copy of the Certificate of Dissolution is filed herewith as Exhibit 4.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit

No.

Description

4.1

Certificate of Dissolution

104

Cover Page Interactive Data File (embedded within the inline XBRL document)

 


 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

CYTEIR THERAPEUTICS, INC.

 

 

 

 

Date:

March 20, 2024

By:

/s/ David Gaiero

 

 

 

Name: David Gaiero
Title: Chief Financial Officer and Treasurer

 

 EX-4.1 2 cyt-ex4_1.htm EX-4.1 EX-4.1

 

STATE OF DELAWARE

 

 

CERTIFICATE OF DISSOLUTION

 

OF

 

CYTEIR THERAPEUTICS, INC.

 

Pursuant to Section 275 of the Delaware General Corporation Law

 

This Certificate of Dissolution of Cyteir Therapeutics, Inc. (the “Corporation”) is being duly executed and filed by the undersigned, as an authorized officer of the Corporation, under the Delaware General Corporation Law (8 Del. C. 1953, § 275) (as amended from time to time, the “DGCL”).

 

It is hereby certified that:

 

FIRST. The name of the Corporation is “Cyteir Therapeutics, Inc.”

 

SECOND. The dissolution of the Corporation has been duly authorized by the Board of Directors of the Corporation and stockholders of the Corporation in accordance with subsections (a) and (b) of Section 275 of the DGCL.

 

THIRD. The date the dissolution was authorized is November 16, 2023.

 

FOURTH. The names and addresses of the directors and officers of the Corporation appear on Exhibit A attached hereto and made a part hereof.

 

FIFTH. The date of filing of the Corporation’s original Certificate of Incorporation in the Office of the Secretary of State of the State of Delaware was the 4th day of June, 2012.

 

SIXTH: This Certificate of Dissolution shall become effective upon filing.

 

 

IN WITNESS WHEREOF, the undersigned has executed this Certificate of Dissolution this 20th day of March, 2024.

 

CYTEIR THERAPEUTICS, INC.

 

By:_/s/ Markus Renschler, M.D.__

Name: Markus Renschler, M.D.

Title: President and Chief Executive Officer

Cyteir Therapeutics, Inc. Certificate of Dissolution

 

EXHIBIT A

 

TO

 

CYTEIR THERAPEUTICS, INC. CERTIFICATE OF DISSOLUTION

 

 

List of Officers and Directors:

 

Name

Title

Business Address

Markus Renschler, MD

President and Chief Executive Officer

c/o Cyteir Therapeutics, Inc.

P.O. Box 80084

Stoneham, Massachusetts 02180

David Gaiero

Chief Financial Officer and Treasurer

c/o Cyteir Therapeutics, Inc.

P.O. Box 80084

Stoneham, Massachusetts 02180

Jean George

Director

c/o Cyteir Therapeutics, Inc.

P.O. Box 80084

Stoneham, Massachusetts 02180

Stephen Sands

Director

c/o Cyteir Therapeutics, Inc.

P.O. Box 80084

Stoneham, Massachusetts 02180

John Thero

Director

c/o Cyteir Therapeutics, Inc.

P.O. Box 80084

Stoneham, Massachusetts 02180

Joseph Zakrzewski

Director (Chairman)

c/o Cyteir Therapeutics, Inc.

P.O. Box 80084

Stoneham, Massachusetts 02180

 

 

 

 EX-101.SCH 3 cyt-20240320.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Pre Commencement Issuer Tender Offer Entity Address, State or Province Trading Symbol Soliciting Material Entity Address, City or Town Written Communications Entity Central Index Key CIK Entity Tax Identification Number Entity Registrant Name Registrant Name Entity Ex Transition Period Document Period End Date Period End Date Entity Address, Postal Zip Code Entity Incorporation State Country Code Local Phone Number City Area Code Pre Commencement Tender Offer Cover [Abstract] Cover Security Exchange Name Entity Emerging Growth Company Amendment Flag Amendment Securities Act File Number Entity Address, Address Line Two Entity Address, Address Line One Security 12b Title Document Type Document Type XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document and Entity Information
Mar. 20, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001662244
Document Type 8-K
Document Period End Date Mar. 20, 2024
Entity Registrant Name Cyteir Therapeutics, Inc.
Entity Incorporation State Country Code DE
Securities Act File Number 001-40499
Entity Tax Identification Number 45-5429901
Entity Address, Address Line One P.O. Box 80084
Entity Address, City or Town Stoneham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02180
City Area Code 857
Local Phone Number 285-4140
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol CYT
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports cyt-20240320.htm cyt-20240320.xsd http://xbrl.sec.gov/dei/2023 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cyt-20240320.htm": { "nsprefix": "cyt", "nsuri": "http://cyteir.com/20240320", "dts": { "inline": { "local": [ "cyt-20240320.htm" ] }, "schema": { "local": [ "cyt-20240320.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_438ad74e-78f6-4005-883e-9d6fa335cdc2", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "cyt-20240320.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_438ad74e-78f6-4005-883e-9d6fa335cdc2", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "cyt-20240320.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "CIK", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://cyteir.com/20240320/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0000950170-24-034247-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-034247-xbrl.zip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cyt-20240320_htm.xml IDEA: XBRL DOCUMENT 0001662244 2024-03-20 2024-03-20 0001662244 false 8-K 2024-03-20 Cyteir Therapeutics, Inc. DE 001-40499 45-5429901 P.O. Box 80084 Stoneham MA 02180 857 285-4140 false false false false Common Stock, $0.001 par value per share CYT NASDAQ true false